Articles
Ways to Start the New Year | 5Y's New Year Book & Film Recommendations
On intellect, wonder, and imagination.
The World Rewards Those Who Stay Pure for the Long Run | 5Y Talk x SenseTime
5Y Capital congratulates SenseTime on its successful listing on the Hong Kong Stock Exchange.
"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
5Y News | No-Code Collaboration Platform "Treelab" Closes Tens of Millions of Dollars in Series A Funding
Empowering enterprises' digital transformation.
Hangzhou Andao Pharma Closes $50 Million Series B to Advance Drug Development for Kidney Disease and Cancer
Addressing the enormous unmet clinical needs in nephrology and oncology.
Unknown Closes Nearly $100 Million in Series B Funding, Launches AI×BT Strategy
Focused on gut microbiome AI-driven drug discovery, with self-developed drug candidates already in registrational clinical trials.
5Y News | AI Microbiome Drug Developer "Unknown" Closes Nearly $100 Million Series B Financing
Launching a new AI×BT strategy.
Chuanwazi Foods Raises Nearly RMB 300 Million in Series A Funding, Aiming to Become China's Go-To Brand for Fresh Sauce
Bold and zesty, there for every meal.
5Y News | Huoban Cloud Completes $40 Million Series B+ Round
Empower more small and medium-sized enterprises to achieve deep digital transformation.
5Y News | Vastai Technologies Completes Two Consecutive Rounds of Series B-1 and B-2 Funding, Raising 1.6 Billion RMB
5Y Capital has been closely following the development of China's AI sector.